GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,559,000 | -20.9% | 155,232 | -9.4% | 5.50% | -33.6% |
| Q2 2020 | $10,815,000 | +144.5% | 171,316 | +97.9% | 8.29% | +71.3% |
| Q1 2020 | $4,423,000 | +21.5% | 86,577 | +15.4% | 4.84% | -38.0% |
| Q3 2019 | $3,640,000 | -78.0% | 75,011 | -76.1% | 7.80% | -12.8% |
| Q2 2019 | $16,528,000 | +264.5% | 314,217 | +266.8% | 8.95% | +18.1% |
| Q1 2019 | $4,534,000 | +3.5% | 85,661 | -19.7% | 7.58% | -37.4% |
| Q4 2018 | $4,379,000 | +11.4% | 106,684 | +3.1% | 12.10% | +233.1% |
| Q3 2018 | $3,931,000 | +76.2% | 103,449 | +109.6% | 3.63% | +65.6% |
| Q2 2018 | $2,231,000 | +109.9% | 49,355 | +124.3% | 2.19% | +64.9% |
| Q1 2018 | $1,063,000 | – | 22,000 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |